This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2007 Jul;13(7):933-4.

doi: 10.1002/ibd.20120.

Infliximab in Crohn's disease: TREAT your friend as if he might become an enemy?

Hans Herfarth¹

Affiliations

Affiliation

¹ Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina School of Medicine, Bioinformatics Bldg., CB #7080, Chapel Hill, NC 27599-7080, USA. ehherf@med.unc.edu

PMID: 17285594
DOI: 10.1002/ibd.20120

Comment

Infliximab in Crohn's disease: TREAT your friend as if he might become an enemy?

Hans Herfarth. Inflamm Bowel Dis. 2007 Jul.

. 2007 Jul;13(7):933-4.

doi: 10.1002/ibd.20120.

Author

Hans Herfarth¹

Affiliation

¹ Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina School of Medicine, Bioinformatics Bldg., CB #7080, Chapel Hill, NC 27599-7080, USA. ehherf@med.unc.edu

PMID: 17285594
DOI: 10.1002/ibd.20120

No abstract available

PubMed Disclaimer

Comment on

Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry.
Lichtenstein GR, Feagan BG, Cohen RD, Salzberg BA, Diamond RH, Chen DM, Pritchard ML, Sandborn WJ. Lichtenstein GR, et al. Clin Gastroenterol Hepatol. 2006 May;4(5):621-30. doi: 10.1016/j.cgh.2006.03.002. Clin Gastroenterol Hepatol. 2006. PMID: 16678077

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.